Формирование и обсуждение прогноза заболевания в неврологической практике. Вопросы коммуникации с неврологическим пациентом
https://doi.org/10.33667/2078-5631-2021-22-55-60
Аннотация
В клинической практике большинство неврологов сталкиваются с вопросами пациентов относительно прогноза заболевания, однако отдельных руководств, посвященных именно этой проблеме, в неврологии практически нет, несмотря на то что исход заболевания – это клинический вопрос, имеющий наибольший приоритет как для врача, так и для пациента. В данной статье разбираются подходы к обсуждению прогноза неврологического заболевания, данные о прогнозе распространенных неврологических заболеваний.
Ключевые слова
неврологические заболевания,
прогноз,
качество жизни,
метастазы,
полиневропатии,
паркинсонизм,
миастения,
инсульт
Об авторах
Е. В. Бриль
Федеральный неврологический центр экстрапирамидных заболеваний и психического здоровья ФГБУ «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна» ФМБА России
Россия
Россия
Бриль Екатерина Витальевна, к.м.н., доцент, рук.
Москва
А. В. Хасина
Кафедра неврологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
Россия
Хасина Анна Владимировна, психолог; эксперт по развитию дружелюбного сервиса в медицине; директор МАС-менеджмент, МВА.
Москва
Ф. А. Аббасов
Федеральный неврологический центр экстрапирамидных заболеваний и психического здоровья ФГБУ «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна» ФМБА России
Россия
Россия
Аббасов Фархад Акиф оглы, врач-невролог
Москва
О. С. Зимнякова
Федеральный неврологический центр экстрапирамидных заболеваний и психического здоровья ФГБУ «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна» ФМБА России
Россия
Россия
Зимнякова Ольга Сергеевна, к.м.н., врач-невролог, доцент кафедры неврологии МБУ ИНО
Москва
Н. В. Федорова
Кафедра неврологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
Россия
Федорова Наталья Владимировна, д.м.н., проф. кафедры неврологии
Москва
Список литературы
1. Prognosis of Neurological Diseases. S. Angelo, L. Giuseppe, Chiapparini, Luisa 2015.
2. Gill T.M. The central role of prognosis in clinical decision making. JAMA. 2012 Jan 11; 307 (2):199–200. DOI: 10.1001/jama.2011.1992.
3. Christakis N.A., Iwashyna T.J. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med. 1998 Nov 23; 158 (21): 2389–95. DOI: 10.1001/archinte.158.21.2389.
4. Holloway R.G., Gramling R., Kelly A.G. Estimating and communicating prognosis in advanced neurologic disease. Neurology. 2013; 80 (8): 764–772. DOI: 10.1212/WNL.0b013e318282509c.
5. Erde E.L., Nadal E.C., Scholl T.O. On truth telling and the diagnosis of Alzheimer's disease. J Fam Pract. 1988 Apr; 26 (4): 401–6.
6. Halkett G.K., Lobb E.A., Oldham L., et al. The information and support needs of patients diagnosed with High Grade Glioma. Patient Educ Couns. 2010 Apr; 79 (1): 112–9. DOI: 10.1016/j.pec.2009.08.013.
7. Clayton J.M., Hancock K.M., Butow P.N., et al. Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust. 2007 Jun 18; 186 (S12): S77–S105. DOI: 10.5694/j.1326–5377.2007.tb01100.x.
8. Finley Caulfeld A, Gabler L., Lansberg M.G., et al. Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. Neurology. 2010 Apr 6; 74 (14): 1096–101. DOI: 10.1212/wnl.0b013e3181d8197f.
9. Hemphill J.C. 3rd, Newman J., Zhao S., et al. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004 May; 35 (5): 1130–4. DOI: 10.1161/01.STR.0000125858.71051.ca.
10. Becker K.J., Baxter A.B., Cohen W.A., et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulflling prophecies. Neurology. 2001 Mar 27; 56 (6): 766–72. DOI: 10.1212/wnl.56.6.766.
11. Fried T.R., Bradley E.H., Towle V.R., et al. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002 Apr 4; 346 (14): 1061–6. DOI: 10.1056/NEJMsa012528.
12. Yourman L.C., Lee S.J., Schonberg M.A., et al. Prognostic indices for older adults: a systematic review. JAMA. 2012 Jan 11; 307 (2): 182–92. DOI: 10.1001/jama.2011.1966.
13. Knibb J.A., Keren N., Kulka A., et al. A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry. 2016 Dec; 87 (12): 1361–1367. DOI: 10.1136/jnnp-2015–312908.
14. Chiò A., Logroscino G., Hardiman O., et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009 Oct-Dec; 10 (5–6): 310–23. DOI: 10.3109/17482960802566824.
15. Osama A. Khairoalsindi, Ahmad R. Abuzinadah. Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives. Neurology Research International, vol. 2018, Article_ID6534150, 12 pages, 2018. https://doi.org/10.1155/2018/6534150.
16. Delgado-López P.D., Corrales-García E.M. Survival in glioblastoma: a review on the impact of treatment modalities. Clin Transl Oncol. 2016 Nov; 18 (11): 1062–1071. DOI: 10.1007/s12094–016–1497-x.
17. Poon M.T.C., Sudlow C.L.M., Figueroa J.D. et al. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis. Sci Rep 10, 11622 (2020). https://doi.org/10.1038/s41598–020–68011–4.
18. Rastogi K., Bhaskar S., Gupta S., et al. Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival. Indian J Palliat Care. 2018 Jul-Sep; 24 (3): 308–312. DOI: 10.4103/ijpc.ijpc_1_18. PMID: 30111944.
19. Hall W., Djalilian H., Nussbaum E. et al. Long-term survival with metastatic cancer to the brain. Med Oncol 17, 279–286 (2000). https://doi.org/10.1007/BF02782192. PMID: 11114706.
20. Stelzer K.J. Epidemiology and prognosis of brain metastases. Surg Neurol Int. 2013 May 2; 4 (Suppl 4): S192–202. DOI: 10.4103/2152–7806.111296. PMID: 23717790.
21. Tremlett H., Zhao Y., Rieckmann P., et al. New perspectives in the natural history of multiple sclerosis. Neurology. 2010 Jun 15; 74 (24): 2004–15. DOI: 10.1212/wnl.0b013e3181e3973f.
22. Rice C.M., Cottrell D., Wilkins A., et al. Primary progressive multiple sclerosis: progress and challenges. J Neurol Neurosurg Psychiatry. 2013 Oct; 84 (10): 1100–6. DOI: 10.1136/jnnp-2012–304140.
23. Kremenchutzky M., Rice G.P., Baskerville J., et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006 Mar; 129 (Pt 3): 584–94. DOI: 10.1093/brain/awh721.
24. Picot M.C., Baldy-Moulinier M., Daurès J.P., et al. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia. 2008 Jul; 49 (7): 1230–8. DOI: 10.1111/j.1528–1167.2008.01579.x.
25. McIntosh A.M., Kalnins R.M., Mitchell L.A., et al. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004 Sep; 127 (Pt 9): 2018–30. DOI: 10.1093/brain/awh221.
26. de Tisi J., Bell G.S., Peacock J.L., et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011 Oct 15; 378 (9800): 1388–95. DOI:10.1016/S0140–6736(11)60890–8.
27. Nashef L., So E.L., Ryvlin P., et al. Unifying the defnitions of sudden unexpected death in epilepsy. Epilepsia. 2012 Feb; 53 (2): 227–33. DOI: 10.1111/j.1528–1167.2011.03358.x.
28. Rizvi S., Ladino L.D., Hernandez-Ronquillo L., et al. Epidemiology of early stages of epilepsy: Risk of seizure recurrence after a frst seizure. Seizure. 2017 Jul; 49: 46–53. DOI: 10.1016/j.seizure.2017.02.006.
29. Baggi F., Andreetta F., Maggi L., et al. Complete stable remission and autoantibody specifcity in myasthenia gravis. Neurology. 2013 Jan 8; 80 (2): 188–95. DOI: 10.1212/wnl.0b013e31827b907b.
30. Wang L., Zhang Y., He M. Clinical predictors for the prognosis of myasthenia gravis. BMC Neurol. 2017 Apr 19; 17 (1): 77. DOI: 10.1186/s12883–017–0857–7.
31. Heyman A., Peterson B., Fillenbaum G., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology. 1996 Mar; 46 (3): 656–60. DOI: 10.1212/wnl.46.3.656.
32. Rait G., Walters K., Bottomley C., et al. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ. 2010 Aug 5; 341: c3584. DOI: 10.1136/bmj.c3584.
33. Williams M.M., Xiong C., Morris J.C., et al. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology. 2006 Dec 12; 67 (11): 1935–41. DOI: 10.1212/01.wnl.0000247041.63081.98.
34. Hodges J.R., Davies R., Xuereb J., et al. Survival in frontotemporal dementia. Neurology. 2003 Aug 12; 61 (3): 349–54. DOI: 10.1212/01.wnl.0000078928.20107.52.
35. Sampson E.L., Candy B., Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev. 2009 Apr 15; 2009 (2): CD007209. DOI: 10.1002/14651858.cd007209.pub2.
36. Willis A.W., Schootman M., Kung N., et al. Predictors of survival in patients with Parkinson disease. Arch Neurol. 2012 May; 69 (5): 601–7. DOI: 10.1001/archneurol.2011.2370.
37. de Lau LM, Verbaan D, van Rooden SM, Marinus J, van Hilten JJ. Relation of clinical subtypes in Parkinson's disease with survival. Mov Disord. 2014 Jan; 29 (1): 150–1. DOI: 10.1002/mds.25652.
38. Ling H. Clinical Approach to Progressive Supranuclear Palsy. J Mov Disord. 2016 Jan; 9 (1): 3–13. DOI: 10.14802/jmd.15060.
39. O'Sullivan S.S., Massey L.A., Williams D.R., et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain. 2008 May; 131 (Pt 5): 1362–72. DOI: 10.1093/brain/awn065.
40. Litvan I., Grimes D.A., Lang A.E. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol. 2000; 82: 183–96.
41. Roos R.A. Huntington's disease: a clinical review. Orphanet J Rare Dis. 2010 Dec 20; 5: 40. DOI: 10.1186/1750–1172–5–40.
42. Long J.D., Langbehn D.R., Tabrizi S.J., et al. Validation of a prognostic index for Huntington's disease. Mov Disord. 2017 Feb; 32 (2): 256–263. DOI: 10.1002/mds.26838.
43. Brønnum-Hansen H., Davidsen M., Thorvaldsen P., et al. Long-term survival and causes of death after stroke. Stroke. 2001 Sep; 32 (9): 2131–6. DOI: 10.1161/hs0901.094253.
44. Fonarow G.C., Saver J.L., Smith E.E., et al. Relationship of national institutes of health stroke scale to 30-day mortality in medicare benefciaries with acute ischemic stroke. J Am Heart Assoc. 2012 Feb; 1 (1): 42–50. DOI: 10.1161/jaha.111.000034.
45. Chandratheva A., Geraghty O.C., Luengo-Fernandez R., et al. ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke. 2010 May; 41 (5): 851–6. DOI: 10.1161/strokeaha.109.570010.
46. Sacco S., Marini C., Toni D., et al. Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke. 2009 Feb; 40 (2): 394–9. DOI: 10.1161/strokeaha.108.523209.
47. Hemphill J.C. 3rd, Bonovich D.C., Besmertis L., et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001 Apr; 32 (4): 891–7. DOI: 10.1161/01.str.32.4.891.
48. Zandbergen E.G., de Haan R.J., Reitsma J.B., et al. Survival and recovery of consciousness in anoxic-ischemic coma after cardiopulmonary resuscitation. Intensive Care Med. 2003 Nov; 29 (11): 1911–5. DOI: 10.1007/s00134–003–1951–4.
49. Wijdicks E.F., Hijdra A., Young G.B., et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006 Jul 25; 67 (2): 203–10. DOI: 10.1212/01.wnl.0000227183.21314.cd.
50. Jiang JY, Gao GY, Li WP, Yu MK, Zhu C. Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma. 2002 Jul; 19 (7): 869–74. DOI: 10.1089/08977150260190456.
51. MRC CRASH Trial Collaborators, Perel P, Arango M, Clayton T, Edwards P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E, Yutthakasemsunt S. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients. BMJ. 2008 Feb 23; 336 (7641): 425–9. DOI: 10.1136/bmj.39461.643438.25.
52. Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, Maas AI. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008 Aug 5; 5 (8): e165; Discussion e165. DOI: 10.1371/journal.pmed.0050165.
53. Netto A.B., Taly A.B., Kulkarni G.B., et al. Mortality in mechanically ventilated patients of Guillain Barré Syndrome. Ann Indian Acad Neurol. 2011 Oct; 14 (4): 262–6. DOI: 10.4103/0972–2327.91942.
54. Rajabally Y.A., Uncini A. Outcome and its predictors in Guillain–Barre syndrome. J Neurol Neurosurg Psychiatry 2012; 83 (7): 711–8. DOI: 10.1136/ jnnp-2011–301882.
55. Walgaard C., Lingsma H. F., Ruts L., et al. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology. 2011 Mar 15; 76 (11): 968–75. DOI: 10.1212/wnl.0b013e3182104407.
56. Peitersen E. The natural history of Bell's palsy. Am J Otol. 1982 Oct; 4 (2): 107–11.
57. Yoo M.C., Soh Y., Chon J., et al. Evaluation of Factors Associated With Favorable Outcomes in Adults With Bell Palsy. JAMA Otolaryngol Head Neck Surg. 2020 Mar 1; 146 (3): 256–263. DOI: 10.1001/jamaoto.2019.4312.
58. Carey T. S., Evans A. T., Hadler N. M., et al. Acute severe low back pain. A population-based study of prevalence and care-seeking. Spine (Phila Pa 1976). 1996 Feb 1; 21 (3): 339–44. DOI: 10.1097/00007632–199602010–00018.
59. Thomson S. Failed back surgery syndrome – defnition, epidemiology and demographics. Br J Pain. 2013 Feb; 7(1): 56–9. DOI: 10.1177/2049463713479096.
60. Bigal M.E., Lipton R.B. The prognosis of migraine. Curr Opin Neurol. 2008 Jun; 21 (3): 301–8. DOI: 10.1097/WCO.0b013e328300c6f5.
61. Lipton R.B., Bigal M.E., Diamond M., et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 Jan 30; 68 (5): 343–9. DOI: 10.1212/01.wnl.0000252808.97649.21.
62. Rajput A., Robinson C.A., Rajput A.H. Essential tremor course and disability: A clinicopathologic study of 20 cases. Neurology. 2004 Mar 23; 62 (6): 932–6. DOI: 10.1212/01.wnl.0000115145.18830.
63. Benito-León J., Louis E.D., Bermejo-Pareja F. Neurological Disorders in Central Spain Study Group. Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry. 2009 Apr; 80 (4): 423–5. DOI: 10.1136/jnnp.2008.147223.
64. Бриль Е.В., Кузнецова О.В., Хасина А.В., Зимнякова О.С. Обучение и развитие навыков коммуникации – неотъемлемая часть профессионализма врача. Главврач. 2019. № 10. С. 9–15.
Рецензия
Для цитирования:
Бриль Е.В., Хасина А.В., Аббасов Ф.А., Зимнякова О.С., Федорова Н.В. Формирование и обсуждение прогноза заболевания в неврологической практике. Вопросы коммуникации с неврологическим пациентом. Медицинский алфавит. 2021;(22):55-60. https://doi.org/10.33667/2078-5631-2021-22-55-60
For citation:
Bril E.V., Khasina A.V., Abbasov F.A., Zimnyakova O.S., Fedorova N.V. Estimation and discussion of prognosis in neurologic practice. Communication issues with patient with neurological disease. Medical alphabet. 2021;(22):55-60. (In Russ.) https://doi.org/10.33667/2078-5631-2021-22-55-60
Просмотров: 225
Послать статью по эл. почте 